Background: The Coronavirus disease 2019 (COVID-19) exploded into a global pandemic, killing over 6.5 million people and forever changing the world. While many developed countries are well into their vaccination campaigns, India outperformed global expectations by providing over 2 billion doses to its citizens and assisting other countries worldwide. Following the emergence of various covid variants, it is critical to comprehend the willingness of Indians to receive additional doses of the newer generation of covid vaccination, as well as the fatigue associated with maintaining the most essential covid appropriate behaviour, masking. This study aimed to determine general public attitudes and perceptions of the COVID-19 vaccine in India. Method: A pan-India cross-sectional analysis was conducted at RUHS college of medical sciences, Jaipur, between October 20, 2022, and December 15, 2022. Through web-based links, a self-administered and semi-structured questionnaire was used to collect data. Results: Of the total responses received (n=391), 55.6% were males, and 43.8% were females. 63.2% have received two doses of the vaccine, while 33.8% have received three doses. 50.9% of respondents were willing to take the fourth dose of the vaccine, 20.5% were utterly unwilling, and 28.6% were undecided. 10.7% of our respondents were utterly reluctant to wear masks, whereas 26.6% always did. Conclusions: Based on the findings, vaccination acceptance in India remains high with 50.9% of applicants willing to take the fourth dose. Furthermore, the pandemic has resulted in the incorporation of face masks into our lifestyles, with the majority of people using a face mask in at least one setting.
Background: Vaccines are a key strategy to stop the COVID19 pandemic. The present study was conducted to assess the incidence of Adverse Drug Reactions to the Covishield vaccine among healthcare workers. Materials and Methods: A cross-sectional, observational, questionnaire-based study was carried out on healthcare workers of R.U.H.S. College of Medical Sciences, Jaipur, Rajasthan. The study tool consisted of a digital questionnaire. Results: The present study was carried out among 316 healthcare workers who received the first dose of the Covishield vaccine. 83 (26.26%) participants complained of side effects after receiving the first dose of the Covishield vaccine. Fatigue (64), fever (52), body ache (40), swelling at the vaccination site (35), headache (25), and pain in the limb (18) were the most prevalent symptoms. Most post-vaccination symptoms were found to be mild. 67 participants showed side effects of vaccination within 24 hours while 16 showed side effects after 24 hours. Conclusion: This study reflects that onefourth of participants complained of side effects after receiving the first dose of the Covishield vaccine. These side effects are not severe and should not be an obstacle to the successful control of the Covid-19 pandemic in India.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.